603077 和邦生物
2021/03 - 三个月2020/122019/122018/122017/12

盈利能力分析
净资产收益率 ROE (%)2.2420.3664.6553.3074.827
总资产报酬率 ROA (%)1.7070.2803.7222.7513.975
投入资产回报率 ROIC (%)1.8690.3094.0982.9364.256

边际利润分析
销售毛利率 (%)26.33918.79622.78322.10325.388
营业利润率 (%)17.6968.3739.7616.88912.576
息税前利润/营业总收入 (%)19.5282.59510.8598.24613.781
净利润/营业总收入 (%)14.5980.0558.4874.96310.663

收益指标分析
经营活动净收益/利润总额(%)95.9942,524.293102.222134.80091.989
价值变动净收益/利润总额(%)2.033154.187-0.2114.9116.168
营业外收支净额/利润总额(%)0.000-2,686.3050.1870.4180.048

偿债能力分析
流动比率 (X)1.0441.0531.2541.9962.715
速动比率 (X)0.8280.8520.7811.3961.908
资产负债率 (%)22.30123.28720.92715.71713.990
带息债务/全部投入资本 (%)15.89616.96114.0459.40312.642
股东权益/带息债务 (%)527.265488.789610.894961.784689.674
股东权益/负债合计 (%)343.581324.591370.612525.401599.152
利息保障倍数 (X)10.6631.13110.0636.21011.490

营运能力分析
应收账款周转天数 (天)28.89836.07030.29035.02750.752
存货周转天数 (天)47.41582.19892.75281.57298.175